GNNSF fundamentals
An in-depth look to Genscript Biotech Corp operating, investing, and financing activities
GNNSF free cash flow for H2 23 is -169.27 M USD. For 2023, GNNSF free cash flow was -437.64 M USD and operating cash flow was -283.62 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM